Source study found

Story checked

Brain activity study reveals five distinct profiles for depression (opens in a new tab)

news-medical.net · 2026-09-23

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

3 supported
4 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail

The story

Brain activity study reveals five distinct profiles for depression

news-medical.net · 2026-09-23

The story’s checkable claims.

Read the original story

NewsLink checks it

Mixed

Every claim we could check holds up. Three of seven claims match the study. This overall rating is based only on the claims we could check. Four claims the study doesn't address.

3 supported
4 not covered

Open claim evidence

The source study

Magnetoencephalography oscillation-based functional connectivity identifies clinically relevant depression phenotypes

Nature Mental Health · 2026

Open source record

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

Reading mode

Scan verdicts. Open evidence only when needed.

Browse by verdict

7 claims in this story

Showing all 7 claimsChoose a verdict to focus the list.

Claim 1 of 7Not coveredIn some individuals, functional connectivity between brain regions was stronger than usual, while in others it was weaker.View evidenceHide evidence

Why this verdict

The abstract-level profile supports that the phenotypes had distinct spectral and spatial connectivity patterns, but it does not specify directional patterns such as stronger-than-usual connectivity in some individuals and weaker-than-usual connectivity in others. That directional statement may require full-text evidence.

Study evidence

Clustering of low-dimensional brain–symptom components from source-reconstructed resting-state MEG connectivity yielded five depression phenotypes.

“five depression phenotypes that were characterized by distinct spectral and spatial patterns and differentiated clinically unique symptom profiles.”

Claim 2 of 7Not coveredOne group with particularly strong inter-region connectivity was associated with more severe substance abuse, and another group with weak connectivity emphasized post-traumatic stress disorder.View evidenceHide evidence

Why this verdict

The profile supports that the five phenotypes corresponded to clinically distinct symptom profiles, but the abstract-level evidence supplied here does not identify substance abuse or PTSD as specific phenotype characteristics, nor does it verify the stated strong-connectivity versus weak-connectivity mapping.

Study evidence

Clustering of low-dimensional brain–symptom components from source-reconstructed resting-state MEG connectivity yielded five depression phenotypes.

“five depression phenotypes that were characterized by distinct spectral and spatial patterns and differentiated clinically unique symptom profiles.”

Claim 3 of 7Not coveredThe finding may explain partly conflicting findings from previous depression studies and supports the idea that depression is not biologically similar for everyone.View evidenceHide evidence

Why this verdict

The profile supports a hedged interpretation that MEG connectivity may capture biological heterogeneity in MDD and that the phenotypes are candidate mechanistic profiles. However, the supplied abstract-level profile does not verify the more specific claim that the finding may explain partly conflicting results from previous depression studies.

Study evidence

Clustering latent brain–symptom components derived from MEG oscillation-based functional connectivity identified five depression phenotypes with distinct spectral and spatial connectivity signatures that correspond to clinically distinct symptom profiles.

“We conducted a cross-sectional study and collected resting-state magnetoencephalography (MEG), structural magnetic resonance imaging and clinical symptom data from 263 patients with MDD and 75 healthy controls.”

Study evidence

Clustering of low-dimensional brain–symptom components from source-reconstructed resting-state MEG connectivity yielded five depression phenotypes.

“five depression phenotypes that were characterized by distinct spectral and spatial patterns and differentiated clinically unique symptom profiles.”

Claim 4 of 7Not coveredThe researchers used magnetoencephalography (MEG) to measure brain activity with millisecond precision, and they said brain measurements are not yet ready to choose the right treatment for patients.View evidenceHide evidence

Why this verdict

The profile supports that the researchers used resting-state MEG and that the phenotypes are candidates requiring future validation before treatment-stratification use, which aligns with the treatment-readiness caveat. However, the supplied abstract-level profile does not state the 'millisecond precision' characterization, so the full combined claim is not fully verifiable at this depth.

Study evidence

“We conducted a cross-sectional study and collected resting-state magnetoencephalography (MEG), structural magnetic resonance imaging and clinical symptom data from 263 patients with MDD and 75 healthy controls.”

Claim 5 of 7SupportedResearchers wanted to determine whether the individuality seen in depression symptoms also appears in brain activity.View evidenceHide evidence

Why this verdict

The abstract-level profile says the study was motivated by MDD heterogeneity and tested whether resting-state MEG oscillation-based functional connectivity, together with brain–symptom modeling, could identify biologically meaningful depression phenotypes. The story frames this as a hedged research aim rather than a result, which is consistent with the paper profile.

Study evidence

“We conducted a cross-sectional study and collected resting-state magnetoencephalography (MEG), structural magnetic resonance imaging and clinical symptom data from 263 patients with MDD and 75 healthy controls.”

Claim 6 of 7SupportedThe analysis identified five groups where functional connectivity between brain regions differed.View evidenceHide evidence

As statedfive groups

Why this verdict

The paper profile states that clustering of low-dimensional brain–symptom components derived from MEG oscillation-based functional connectivity identified five depression phenotypes with distinct spectral and spatial connectivity patterns. Calling these five groups with differing functional connectivity is consistent with the abstract-level evidence.

Study evidence

“We conducted a cross-sectional study and collected resting-state magnetoencephalography (MEG), structural magnetic resonance imaging and clinical symptom data from 263 patients with MDD and 75 healthy controls.”

Study evidence

Clustering of low-dimensional brain–symptom components from source-reconstructed resting-state MEG connectivity yielded five depression phenotypes.

“five depression phenotypes that were characterized by distinct spectral and spatial patterns and differentiated clinically unique symptom profiles.”

Claim 7 of 7SupportedResearchers at the University of Helsinki measured brain activity in 263 people with major depressive disorder and 75 healthy control subjects.View evidenceHide evidence

As stated263 patients and 75 controls

Why this verdict

The profile directly reports a cross-sectional study collecting resting-state MEG, structural MRI, and clinical symptom data from 263 patients with MDD and 75 healthy controls.

Study evidence

“We conducted a cross-sectional study and collected resting-state magnetoencephalography (MEG), structural magnetic resonance imaging and clinical symptom data from 263 patients with MDD and 75 healthy controls.”

Study evidence

Clustering of low-dimensional brain–symptom components from source-reconstructed resting-state MEG connectivity yielded five depression phenotypes.

“five depression phenotypes that were characterized by distinct spectral and spatial patterns and differentiated clinically unique symptom profiles.”

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

The abstract does not provide quantitative effect sizes, confidence intervals, statistical test details, or full clustering/preprocessing details.
The story does not discuss the absence of quantitative effect sizes or detailed model-validation information in the abstract-level evidence. This omission matters for judging the strength and reproducibility of the phenotype distinctions.
From cross-sectional observational MEG study

4 things the story did carry across

The paper is a cross-sectional observational human MEG study of 263 people with MDD and 75 healthy controls.
The primary analysis used source-reconstructed resting-state MEG oscillation-based functional connectivity, brain–symptom latent components, and clustering to identify five depression phenotypes.
The five phenotypes were characterized by distinct spectral and spatial connectivity patterns and clinically distinct symptom profiles.
The findings are candidate mechanistic phenotypes requiring future validation and are not yet established for treatment selection or treatment stratification.

Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoData-driven identification of major depressive disorder (MDD) “oscillation phenotypes” using resting-state MEG oscillation-based functional connectivity and brain–symptom latent components, yielding clusters that correspond to clinically distinct symptom profiles.Cross-sectional observational human cohort studyExpand

In plain English

Cross-sectional MEG study (263 MDD, 75 healthy controls) used source-reconstructed oscillation-based functional connectivity (two coupling-mode measures), multivariate brain–symptom dimensionality reduction to latent components, and clustering on those components to derive five data-driven depression phenotypes that show distinct spectral/spatial connectivity patterns and correspond to clinically distinct symptom profiles.

Key findings

Clustering latent brain–symptom components derived from MEG oscillation-based functional connectivity identified five depression phenotypes with distinct spectral and spatial connectivity signatures that correspond to clinically distinct symptom profiles.

“We conducted a cross-sectional study and collected resting-state magnetoencephalography (MEG), structural magnetic resonance imaging and clinical symptom data from 263 patients with MDD and 75 healthy controls.”

What this piece can’t prove

The abstract frames the phenotypes as candidates for future validation and treatment-stratification studies, indicating that replication/validation is needed.

2 further details could not be confirmed from the summary.

2human in vivoCharacterization/validation of the identified phenotypes via their spectral and spatial connectivity patterns and their differentiation from healthy controls (and/or across subgroups) within the same cross-sectional dataset.cross-sectional observational MEG studyExpand

In plain English

Within a cross-sectional cohort (263 MDD, 75 controls) resting-state source-reconstructed MEG connectivity (two coupling-mode measures) was reduced to low-dimensional brain–symptom components and clustered to define five depression phenotypes. These phenotypes are reported to have distinct spectral and spatial connectivity patterns and to show clinically distinct symptom profiles when characterized within the same dataset.

Key findings

Clustering of low-dimensional brain–symptom components from source-reconstructed resting-state MEG connectivity yielded five depression phenotypes.
The five phenotypes showed distinct spectral and spatial patterns of oscillatory connectivity and were associated with clinically unique symptom profiles.

“five depression phenotypes that were characterized by distinct spectral and spatial patterns and differentiated clinically unique symptom profiles.”

What this piece can’t prove

Abstract does not provide quantitative effect sizes, confidence intervals, or statistical test details for the phenotype distinctions.
While healthy controls were collected, the abstract does not specify the nature or results of any case–control contrasts for the phenotypes.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer